Skip to main content
ASLMS 45th Annual Conference (2026) Main banner

    Shlomit Halachmi, MD, PhD

    Building 66

    Dr. Shlomit Halachmi studied chemical engineering and biology at MIT, after which completed the MD PhD program at Harvard Medical School. Her doctoral work, in cell and molecular biology, identified the co-factors that allow steroid receptors to regulate gene expression differentially in normal and cancer cells. After completing dermatology training at the combined Boston University/Tufts University residency program, she practiced in both private and hospital-based clinics with a focus on laser/procedural dermatology and served as a clinical advisor for medical device manufacturers. In addition, she has experience as a project manager in drug development and as VP of medical affairs in MedTech. Most recently she provided clinical and regulatory reviews for energy-based devices and AI/ML diagnostics at FDA for 12 years. She is currently the founder and CEO of Building 66, a clinical and regulatory strategic consulting practice.

    Presentation(s):